* Equillium Inc EQ.OQ EQ.O is expected to show a fall in
quarterly revenue when it reports results on March 21
(estimated) for the period ending December 31 2023
* The La Jolla California-based company is expected to
report a
59.2% decrease in revenue to $6.425 million from $15.76 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Equillium Inc is for a
loss
of 17 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Equillium
Inc is
$7.00, above its last closing price of $2.64.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.14 -0.17 -0.11 Beat 35.3
Jun. 30 2023 -0.14 -0.17 -0.10 Beat 40.6
Mar. 31 2023 -0.25 -0.27 -0.11 Beat 59.6
Dec. 31 2022 0.41 -0.03 0.08 Beat 407.7
Sep. -0.39 -0.38 -0.40 Missed -6
30 2022
Jun. 30 2022 -0.41 -0.41 -0.41 Met 1.2
Mar. 31 2022 -0.37 -0.37 -0.45 Missed -20.8
Dec. 31 2021 -0.37 -0.34 -0.36 Missed -5.3
This summary was machine generated March 19 at 11:05 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)